Hope Biosciences launches stem cell trial for children with arthritis (Juvenile Rheumatoid/Idiopathic Arthritis)
Hope Biosciences has reportedly received FDA authorization to conduct a pediatric clinical trial using their adipose(fat)-derived mesenchymal stem cells (HB-adMSCs) to assess their impact on juvenile idiopathic arthritis (JIA) in children aged...
